ArticleBMC molecular and cell biology2022

lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.

Yi Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.